Could an NLRP3 inhibitor be the one drug to conquer common diseases?

A large number of diseases have been linked to the NLRP3 inflammasome. The race is on to develop drugs that disrupt it

Source: Chemical and Engineering News - February 17, 2020 Category: Chemistry Authors: Ryan Cross Source Type: research